Announcement: Introducing iLumOS by Lumenci: Expert-Powered AI Platform for Patent Intelligence

Texas Instruments Patent Portfolio Analysis 

Follow Lumenci:

Texas Instruments

Disclaimer: 
This report has been updated through 14 October 2025. The information is provided for reference only and does not represent any opinion, recommendation, or endorsement. 

Overview 

Texas Instruments, a global semiconductor and electronics company, maintains a large and technically diverse patent portfolio. Its filings primarily focus on analog circuits, embedded systems, and semiconductor manufacturing, reflecting its core strengths in chip design and power management. The portfolio is mature, with a steady flow of new assets complementing decades of foundational innovation. 

Key Metrics:

  • Total Patents: 72,979 
  • Simple Families: 35,692 
  • Extended Families: 32,737 
  • Jurisdictions Covered: 56 
  • Litigated Patents: 42 
  • Challenged Patents: 1 

Asset Status:

  • Active Grants: 19,157 
  • Active Applications: 5,302 
  • Expired: 2,968 
  • Expired due to Term: 23,606 
  • Expired due to Fees: 5,617 
  • Withdrawn: 3,215 
  • Abandoned Applications: 12,911 
  • Inactive Applications: 6 

New Analysis Monthly Alerts. No Spam!

Jurisdictional Distribution

Texas Instruments’ patents span 56 jurisdictions, with the United States representing the majority of filings. 

texas Jurisdictional Distribution
  • United States (US): 40,230 
  • Japan (JP): 8,255 
  • European Patent Office (EP): 5,333 
  • China (CN): 4,166 
  • World Intellectual Property Organization (WO): 3,814 
  • Germany (DE): 3,672 
  • South Korea (KR): 2,441 
  • Taiwan (TW): 1,265 
  • United Kingdom (GB): 786 
  • Canada (CA): 535 

Total Patents across jurisdictions: 72,979

Technological Distribution  
texas Technological Distribution
  • Semiconductor: 18,814
  • Computer Systems and Components: 16,466 
  • Networking: 10,403 
  • Software: 5,681 
  • Consumer Electronics: 2,185 
  • Industrial: 2,184 
  • Consumer Goods: 2,084 
  • Imaging: 1,079 
  • Healthcare: 482 
  • Automotive: 153 
  • Retail: 47 

Citations 

Top Cited Patents 

  • US5629981A – 1,455 citations 
  • US5523193A – 1,216 citations 
  • US5335276A – 1,098 citations 
  • US5061049A – 1,074 citations 
  • US6013553A – 1,026 citations 
  • US7630841B2 – 1,014 citations 
  • US4441791A – 1,009 citations 
  • US5096279A – 895 citations 
  • US5083857A – 883 citations 
  • US5773991A – 875 citations 

Top Citing Patents 

  • US7058862B2 – 417 backward citations 
  • US6769080B2 – 380 backward citations 
  • US6728915B2 – 374 backward citations 
  • US6763485B2 – 368 backward citations 
  • US6975980B2 – 349 backward citations 
  • US6467605B1 – 276 backward citations 
  • US6990620B2 – 226 backward citations 
  • US7058871B2 – 225 backward citations 
  • US6996761B2 – 225 backward citations 
  • US6727722B2 – 215 backward citations 

Top Cited Assignees (Backward Citations) 

  • Texas Instruments, Inc. – 22,081 
  • International Business Machines Corporation – 7,288 
  • Renesas Electronics Corporation – 6,618 
  • Intel Corporation – 6,404 
  • Samsung Electronics Co. Ltd. – 6,003 
  • Toshiba Corporation – 5,971 
  • NXP Semiconductors NV – 5,009 
  • Broadcom, Inc. – 4,609 
  • Fujitsu Limited – 4,460 
  • Panasonic Holdings Corporation – 4,302 

Top Citing Assignees (Forward Citations) 

  • Texas Instruments, Inc. – 14,203 
  • Samsung Electronics Co. Ltd. – 6,973 
  • International Business Machines Corporation – 5,564 
  • Intel Corporation – 5,003 
  • Renesas Electronics Corporation – 4,758 
  • NXP Semiconductors NV – 4,189 
  • Infineon Technologies AG – 4,065 
  • Qualcomm, Inc. – 3,634 
  • STMicroelectronics NV – 3,564 
  • Micron Technology, Inc. – 3,493 

Litigation Activities 

Texas Instruments has been involved in limited patent litigation activity over the years, with most cases originating in the early 2000s. A total of 42 patents have been litigated, primarily against other operating companies, reflecting a moderate enforcement profile. 

Top Plaintiffs 

  • Texas Instruments, Inc. – 22 (Operating Company), 1 (NPE) 
  • Arrivalstar SA – 3 (NPE) 
  • Melvino Technologies Limited – 3 (NPE) 
  • Nanolife Health, Inc. – 2 (NPE) 
  • Ronald A Katz Technology Licensing LP – 2 (NPE) 

Top Defendants 

  • Analog Devices, Inc. – 4 
  • Hexagon AB – 2 
  • Fujitsu Limited – 1 
  • Hitachi, Ltd. – 1 
  • Panasonic Holdings Corporation – 1 

Top Venues 

  • E.D. Texas – 6 (Operating Company), 1 (NPE)
  • D. Delaware – 5 (Operating Company) 
  • E.D. New York – 3 (NPE) 
  • N.D. Illinois – 2 (NPE) 

Ownership and Acquisition 

Ownership Type 

  • Acquired Patents: 1,899 
  • Originally Assigned Patents: 71,080 

Sources of Acquired Patents 

  • Operating Companies: 1,049 
  • Universities: 9 
  • NPEs: 1 
  • Other Sources: 325 

Texas Instruments’ portfolio is overwhelmingly composed of originally assigned patents, reflecting its strong in-house R&D capabilities. The relatively small number of acquisitions primarily come from other operating companies, supporting targeted technology integration rather than large-scale IP consolidation. 

Patent Portfolio Ageing by Estimated Expiration 
Patent Portfolio Ageing by Estimated Expiration
Patenting Activity by Publication/Issue Year 
Patenting Activity by Publication

Notable Acquisitions and M&A 

  • 2011 – National Semiconductor (US$6.5 B) 
    TI acquired National Semiconductor to deepen its analog portfolio and expand production scale. The merger unified two major analog players, strengthening TI’s dominance in signal chain and power solutions. 
  • 2000 – Burr-Brown (US$7.6 B) 
    This acquisition bolstered TI’s precision analog and mixed-signal expertise, reinforcing its leadership in data conversion and amplifier technologies. 
  • 2009 – Luminary Micro 
    The acquisition enhanced TI’s embedded microcontroller lineup, expanding its ARM-based offerings and solidifying its position in embedded processing markets. 

Business Performance 

Texas Instruments (Ticker: TXN) is a publicly traded company. 

  • FY 2024 revenue: approximately US$15.64 billion, down ~11% YoY amid semiconductor cyclicality. 
  • Analog products contributed ~78% of total revenue, underscoring the company’s leadership in core chip technologies. 
  • Q3 2025 guidance: revenue between US$4.45–4.80 billion, supported by strong industrial and automotive demand. 
  • Under the CHIPS & Science Act, TI will receive up to US$1.6 billion to support fabrication facilities in Texas and Utah. 
  • TI anticipates a significant free cash flow increase by 2026, driven by capacity expansion and capital efficiency. 

Leadership (2025) 

  • Haviv Ilan – President & Chief Executive Officer 
  • Ahmad Bahai – Senior Vice President & Chief Technology Officer 
  • Rafael Lizardi – Senior Vice President & Chief Financial Officer 
  • Krunali Patel – Senior Vice President & Chief Information Officer 

Headquarters 

Texas Instruments Incorporated 
12500 TI Boulevard, Dallas, Texas 75243, United States 

Conclusion

 

Texas Instruments’ patent portfolio is among the largest in the semiconductor industry, comprising nearly 73,000 patents across 56 jurisdictions. The portfolio spans analog, embedded, and mixed-signal technologies and reflects long-term investment in research and development. 

Litigation activity has been limited, with most patents maintained for defensive and operational purposes. The company’s strategy emphasizes internal innovation, selective acquisitions, and manufacturing expansion. 

Relevant Reads

ExxonMobil Patent Portfolio Analysis - Lumenci 
Read More >
Patent portfolio
Intuitive Surgical Patent Portfolio Analysis -Lumenci
Read More >
patent portfolio (25) (convert
UBTECH Robotics Patent Portfolio Analysis -Lumenci
Read More >
patent portfolio EA
Electronic Arts Inc. (EA) Patent Portfolio Analysis
Read More >

Share on:

Need a Detailed
Texas Instruments
 
Patent Portfolio Report

Reach out and we’ll get you what you need.